Posted on August 4, 2025 Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for PrBuccolam® in Canada and announces its approval by Health Canada. Read More
Posted on June 26, 2025 Pendopharm® and KalVista® Partner to Bring First Oral On-Demand HAE Treatment to Canada Read More
Posted on November 24, 2015 CANADIAN FOOTBALL LEAGUE BRINGS ATTENTION TO PLAYER HEALTH THROUGH MULTI-YEAR MARKETING PARTNERSHIP WITH MONOVISC® Read More